- $970.57m
- $180.86m
- $229.99m
- 65
- 31
- 71
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 106 | 180 | 302 | 208 | 230 |
Cost of Revenue | |||||
Gross Profit | 27.8 | 61.9 | 128 | 89.4 | 107 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 179 | 250 | 486 | 376 | 336 |
Operating Profit | -73.4 | -69.8 | -184 | -168 | -106 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -70.4 | -66.7 | -175 | -144 | -57.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -70.5 | -66.9 | -175 | -146 | -60.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -70.5 | -66.9 | -175 | -146 | -60.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -73.9 | -66.9 | -175 | -146 | -60.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.132 | -0.12 | -0.359 | -0.264 | -0.09 |